{"id":190125,"name":"CERESCAN","slug":"cerescan","state":"CO","country":"United States of America","description":"High Definition Brain Imaging","totalSpending":280000,"filings":34,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":120000},{"year":2025,"income":160000}],"issues":["HCR"],"firms":["BELL & LINDSAY, INC."],"lobbyists":["MARK LINDSAY","MICHAEL HAYCOCK","MOLLY TERRY","ANTHONY FIMOGNARI","ERIK DELL"],"govEntities":["Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE","Executive Office of the President (EOP)"],"sampleDescriptions":["We are engaged in a proactive and reactive education initiative with the US Federal Government to help promote healthcare quality enhancement and cost reduction for the government and private sector.","We are engaged in a proactive and reactive education initiative with the US Federal Government to help promote healthcare quality enhancement and cost reduction for the government and private sector.","We are engaged in a proactive and reactive education initiative with the US Federal Government to help promote healthcare quality enhancement and cost reduction for the government and private sector.","We are engaged in a proactive and reactive education initiative with the US Federal Government to help promote healthcare quality enhancement and cost reduction for the government and private sector.","We are engaged in a proactive and reactive education initiative with the US Federal Government to help promote healthcare quality enhancement and cost reduction for the government and private sector."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}